
    
      The first Cohort (Cohort 1) utilizes a treatment interval of at least 14 days between
      treatments with longer treatment intervals being allowed depending on a specific patient's
      clinical response.Twenty Subjects (2 years and older) are targeted completing EOS visit in
      Cohort 1.

      The second Cohort (Cohort 2) utilizes a treatment interval of 21 days between treatments.
      Paring of lesions is allowed. Approximately 35 subjects (12 years and older) will be enrolled
      in Cohort 2. Up to 4 sites will participate in the study.
    
  